LCP Health Analytics at ISPOR Europe 2025
This content is AI generated, click here to find out more about Transpose™.
For terms of use click here.
The ISPOR Europe 2025 conference, themed “Powering Value and Access Through Patient-Centered Collaboration”, will be held on 9-12 November 2025 in Glasgow.
LCP Health Analytics are delighted to be attending and presenting our pioneering work at the leading conference for health economics and outcomes research (HEOR). It’s going to be a busy few days and we would love to connect with you whilst there!
Visit us at Stand 1202 throughout the conference. We look forward to meeting you!
Also attending? Meet with us at ISPOR
Come and chat to usOur team will also be presenting 15 posters on a range of timely and impactful topics, including the new era of Joint Clinical Assessment (JCA), health equity, novel statistical methods and broader value.
Further details on poster titles and timings of sessions are below:
|
Poster Title |
Poster Session |
|
A review of the UK's international recognition procedure and its role in expediting access to innovative treatments |
|
|
An interactive tool to select comparative efficacy and safety analysis methods for rapid feasibility assessment |
For further information please contact Mei Sum Chan |
|
Assessing productivity in health technology assessment: a comparative review of human capital and friction cost approaches in Europe |
|
|
Does the joint clinical assessment (JCA) enable health equity across Europe? a review of HTA practices in the EU? |
|
|
Domain attrition in the IWQOL series and the challenges of factor-only item reduction |
|
|
Estimated healthcare resource utilisation and costs associated with semaglutide life expectancy gains in a real-world population with CVD and overweight or obesity in the United Kingdom |
For further information please contact Sara Holloway |
|
Mapping the measurement gap: patient-reported outcomes across the obesity care continuum in the GLP-1 era |
|
|
Impact of Companion Diagnostics (CDx) on reimbursement outcomes of breast cancer and NSCLC therapies |
|
|
Integrating patient perspectives in HTA - What can we learn to inform HTA-focused value communications? |
|
|
Estimating quality-adjusted life expectancy (QALE) by ethnicity for application in distributional cost-effectiveness analysis (DCEA) |
|
|
Evaluating the role of societal perspectives in the EU Joint Clinical Assessment framework and in EU-27 health technology assessment guidelines |
|
|
Patient involvement in the development of obesity and weight loss specific patient reported outcome measures |
|
|
Missing health state utility values (HSUV) in NICE oncology appraisals: A systematic review of utility data reporting and handling practices |
For further information please contact Matthew Hankins |
|
Quantifying the fiscal value of prevention programmes for depression |
|
|
Understanding Drivers on Healthcare Resource Utilisation Costs Among People Living With Obesity in UK Clinical Practice |
For further information please contact Sara Holloway |
Join us for casual drinks and canapés at our stand on Monday 10 November, and Tuesday 11 November, from 5:30PM. It's a great opportunity to relax and discuss the day's presentations.
Want to meet more formally with one of our team whilst there? Set up a coffee chat with one of our HEOR, market access or RWE experts.
